<i>MUTYH</i> as an Emerging Predictive Biomarker in Ovarian Cancer

by Megan L. Hutchcraft, Holly H. Gallion, Jill M. Kolesar
Published 2021-01-01

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance

by Justin W. Gorski, Zhuwei Zhang, J. Robert McCorkle, Jodi M. DeJohn, Chi Wang, Rachel W. Miller, Holly H. Gallion, Charles S. Dietrich, Frederick R. Ueland, Jill M. Kolesar
Published 2021-08-01

Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery

by Christopher G. Smith, Daniel L. Davenport, Justin Gorski, Anthony McDowell, Brian T. Burgess, Tricia I. Fredericks, Lauren A. Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles S. Dietrich, Holly H. Gallion, Edward J. Pavlik, John R. van Nagell, Frederick R. Ueland
Published 2019-07-01

Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence &amp; Aggressiveness

by Edward J. Pavlik, Christopher Smith, Taylor S. Dennis, Elizabeth Harvey, Bin Huang, Quan Chen, Dava West Piecoro, Brian T. Burgess, Anthony McDowell, Justin Gorski, Lauren A. Baldwin, Rachel W. Miller, Christopher P. DeSimone, Charles Dietrich, Holly H. Gallion, Frederick R. Ueland, John R. van Nagell
Published 2020-01-01